Skip to Main Content
Pitt Home
Find People
School of Medicine
Toggle navigation
Skip Navigation Links
Home
About
Leadership
Mission
Department Statistics
Building Information
Thomas E. Starzl BST
Biomedical Science Tower 3
Directory
Primary Faculty
Secondary Faculty
Graduate Students
Fellows
Administrative Staff
Research Staff
Adjunct Faculty
Department Alumni
Research
Research Areas
Labs
Equipment
Funding Opportunities
Faculty Development Program
Responsible Conduct of Research
Shops
Cell Biology/Pharmacology Machine Shop
Education
Molecular Pharmacology Graduate Program
Current Students
Current Student Roster
Student Publications
Diversity, Accessibility, and Counseling
Student Awards
MPGP News
Prospective Students
Welcome from the Director
Research Opportunities
PhD Track
MD/PhD Track
Financial Aid
Graduate Faculty
Graduate Courses
Grad Student Lab Rotations
Grad Student Events
Grad Student Event Calendar
Graduate Student Event Schedule
Alumni/Career Development
Alumni
Alumni Contacts
Molecular Pharmacology Facebook Group
Molecular Pharmacology Student-Alumni Network (LinkedIn)
SOM Graduate Studies - Career and Professional Development
Executive Committee
Student Testimonials
IBGP
Grad Student Funding Opportunities
NIH T32 Training Grant
Outcomes
Predoctoral Fellowship
Admissions
Student Handbook & General Timeline
Links
Useful Links
School of Medicine
PubMed
Remote Resources
Biomedical Masters Program
Undergraduate Research
Summer Fellowships
Lab Rotations
Graduate Fellowships
News
Events
Calendar
Seminar Series
Links
Contact
Opportunities
Department
PORtal
Computer Resources Access Request
IT-Equipment-Facilities Support Request
Poster Requests
Reservation Calendars
Badge Access Request
Home
>
Events
>
Calendar
>
“Is NOX2 a targetable immune checkpoint in cancer?...
Pharmacology & Chemical Biology Seminar Series
1/26/2023 - 12:00 PM-1:00 PM
“Is NOX2 a targetable immune checkpoint in cancer?”
Anna Martner, PhD
Sahlgrenska Center for Cancer Reserach
University of Gothenburg
**VIRTUAL SEMINAR**
“Anna Martner´s research group studies the role of the myeloid cell enzyme NOX2 in cancer. Myeloid cells express high levels of NOX2 that generate reactive oxygen species (ROS) that are pivotal for innate immune defense against microbes. However, when extracellularly released ROS also exert immunosuppression and thereby promote growth and metastatic spread of malignant cells. NOX2-inhibitors have been shown to enhance immunosurveillance in vitro and in vivo. NOX2 may thus be a therapeutic target in cancer. “
Contact
Melanie Hoffner